August 2021 FDA Recall Carvedilol by Zydus Pharmaceuticals (usa) Inc (D-0753-2021 - Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle)

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals (usa) Inc on August 13, 2021 for the product Carvedilol. The FDA reported the reason for recall as presence of foreign tablets/capsules; report of two paroxetine tablets were found in the bottle. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0753-2021

Reason for Recall
Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle
Initiated
08-13-2021
Reported
08-25-2021
Quantity
2880 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals (USA) Inc
Nationwide in the US
Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05

Batch or Lot Expiration Information

Lot# Z006279, exp 12/31/2022